TransMedics Group
Stock Forecast, Prediction & Price Target
TransMedics Group Financial Estimates
TransMedics Group Revenue Estimates
TransMedics Group EBITDA Estimates
TransMedics Group Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $30.26M N/A | $93.45M 208.83% | $241.62M 158.53% | Avg: $527.95M Low: $502.28M High: $545.90M avg. 118.50% | Avg: $654.34M Low: $632.73M High: $682.29M avg. 23.93% | Avg: $832.3M Low: $804.81M High: $867.85M avg. 27.19% | Avg: $991.95M Low: $959.19M High: $1.03B avg. 19.18% |
Net Income
% change YoY
| $-44.21M N/A | $-36.23M 18.05% | $-25.02M 30.92% | Avg: $53.48M Low: $39.67M High: $64.05M avg. 313.68% | Avg: $85.04M Low: $58.53M High: $89.09M avg. 59.01% | Avg: $91.59M Low: $87.65M High: $96.67M avg. 7.69% | Avg: $120.63M Low: $115.46M High: $127.33M avg. 31.71% |
EBITDA
% change YoY
| $-40.30M N/A | $-32.43M 19.51% | $-7.60M 76.56% | Avg: $-345.85M Low: $-357.61M High: $-329.04M avg. -4448.94% | Avg: $-428.64M Low: $-446.96M High: $-414.49M avg. -23.93% | Avg: $-545.22M Low: $-568.51M High: $-527.22M avg. -27.19% | Avg: $-649.80M Low: $-677.57M High: $-628.35M avg. -19.18% |
EPS
% change YoY
| -$1.6 N/A | -$1.23 23.12% | -$0.77 37.39% | Avg: $1.5 Low: $1.22 High: $1.97 avg. 294.78% | Avg: $2.35 Low: $1.8 High: $2.74 avg. 56.37% | Avg: $2.82 Low: $2.7 High: $2.97 avg. 20.09% | Avg: $3.71 Low: $3.55 High: $3.92 avg. 31.71% |
Operating Expenses
% change YoY
| $60.58M N/A | $96.70M 59.62% | $182.82M 89.04% | Avg: $469.04M Low: $446.24M High: $484.99M avg. 156.56% | Avg: $581.33M Low: $562.13M High: $606.16M avg. 23.93% | Avg: $739.43M Low: $715.01M High: $771.02M avg. 27.19% | Avg: $881.27M Low: $852.16M High: $918.92M avg. 19.18% |
FAQ
What is TransMedics Group stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 103.02% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 39.67M, average is 53.48M and high is 64.05M.
What is TransMedics Group stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 47.20% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $502.28M, average is $527.95M and high is $545.90M.
What is TransMedics Group stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 100.74% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $1.22, average is $1.5 and high is $1.97.
What is the best performing analyst?
In the last twelve months analysts have been covering TransMedics Group stock. The most successful analyst is George Sellers.